Dr. Williams served as head of rheumatology research at University of Pennsylvania with over 100 peer reviewed publications. At GlaxoSmithKline he was Head of Experimental Medicine and VP of Clinical Pharmacology. As VP of Exploratory Development at Incyte he brought over a dozen compounds into the clinic and established proof-of-concept for compounds in multiple disease areas including rheumatoid arthritis, psoriasis and diabetes.

Mr. Hoffman has over 20 years’ experience in the pharmaceutical industry. He worked in the laboratory of Dr. Bryan Brewer at the NIH. At Merck and 3-D Pharmaceuticals he focused his efforts on receptor- based peptidomimetics and structure based drug design. At GSK he led a team of medicinal chemists that developed novel, broad-spectrum antibiotics and progressed it into the clinic. Mr. Hoffman has a Master’s Degree in Business Administration.

Professor of Medicine, Pediatrics, Biochemistry, Microbiology, Pathology and Laboratory Medicine; Vice-Chairman, Division of Medicine, and Director of the Cancer Center; Boston University School of Medicine. Dr. Faller is a recognized international expert in biochemistry, cell biology, nanomedicine, hematology and oncology. He has founded several biotechnology companies, including HemaQuest which is currently in phase 3 clinical trials.

University Distinguished Professor of Chemistry, Colorado State University; Recipient, 2011 Ernest Guenther Award in the Chemistry of Natural Products. Dr. Williams is a recognized international expert in organic synthesis of pharmacologically active molecules. Dr. Williams is a consultant for many successful biotechnology companies including HemaQuest, Xcyte and Microcide Pharmaceuticals.